Is Amphastar Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: AMPH) stock is to Buy AMPH stock.
Out of 2 analysts, 1 (50%) are recommending AMPH as a Strong Buy, 0 (0%) are recommending AMPH as a Buy, 1 (50%) are recommending AMPH as a Hold, 0 (0%) are recommending AMPH as a Sell, and 0 (0%) are recommending AMPH as a Strong Sell.
What is AMPH's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: AMPH) forecast ROE is N/A, which is considered weak.
What is AMPH's Price Target?
According to 2 Wall Street analysts that have issued a 1 year AMPH price target, the average AMPH price target is $57.00, with the highest AMPH stock price forecast at $70.00 and the lowest AMPH stock price forecast at $44.00.
On average, Wall Street analysts predict that Amphastar Pharmaceuticals's share price could reach $57.00 by Jul 25, 2024. The average Amphastar Pharmaceuticals stock price prediction forecasts a potential upside of 25.25% from the current AMPH share price of $45.51.
What is AMPH's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: AMPH) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.05%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.